Clinical trial · Interventional
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
Mobile Health Study and Enhanced Symptom Monitoring to Prevent Severe Illness From COVID-19 in Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The established Insight(TM) mHealth Platform, a component of the Stephenson Cancer Center (SCC) mHealth Shared Resource will be used to create the "Symptom Tracker" app. The Symptom Tracker (Insight(TM)) app will enable real-time monitoring of cancer patient symptoms that are consistent with early signs of SARS-CoV-2 infection in this high-risk population by automatically (and securely) transferring this information to health care providers. The primary aim of this study is to determine the feasibility, ease of use, and perceived utility of this app to monitor symptoms and health risk behaviors among cancer patients currently receiving chemotherapy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Covid-19 | — | UNRESOLVED | — |
| Sars-CoV2 | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| mHealth Assessments | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- No Elevated Risk for COVID-19 Detected
- description
- Continue daily mHealth assessments
- interventionNames
- Other: mHealth Assessments
- type
- EXPERIMENTAL
- label
- Elevated Risk for COVID-19 Detected
- description
- Daily mHealth assessments and telemedicine/nurse triage. If non-emergent intervention, enhanced symptom monitoring will occur.
- interventionNames
- Other: mHealth Assessments
Primary outcomes (6)
- measure
- Proportion of Smartphone Based Surveys Completed
- timeFrame
- up to 24 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Demonstrate \> 6th grade English literacy level (i.e., phone based EMAs require \>6th grade literacy) 2. Present for care at the Stephenson Cancer Center at the University of Oklahoma Health Sciences Center 3. Are currently receiving systemic chemotherapy by intravenous infusion or by orally delivered medication 4. Are greater than or equal to 18 years of age 5. Are willing and able to complete surveys on their personal smartphone or a study provided smartphone 6. Are willing and able to provide informed consent Exclusion Criteria: * None
References
Publications (1)
- DERIVEDShao R, Neil JM, Chen M, Hannafon B, Nipp R, Montgomery A, Frank-Pearce SG, Moxley K, Richardson DL, Elliott J, Benson L, Gossett AG, Businelle MS. A mobile health app for real-time symptom monitoring in patients with cancer during COVID-19: feasibility, acceptability, and utility. BMC Cancer. 2026 Feb 20;26(1):408. doi: 10.1186/s12885-026-15772-2. PMID 41715027